These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19616226)

  • 1. Primary cryoablation nadir prostate specific antigen and biochemical failure.
    Levy DA; Pisters LL; Jones JS
    J Urol; 2009 Sep; 182(3):931-7. PubMed ID: 19616226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
    Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
    J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival.
    Nguyen CT; Reuther AM; Stephenson AJ; Klein EA; Jones JS
    J Urol; 2009 Jan; 181(1):75-80. PubMed ID: 19012927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definition of biochemical success following primary whole gland prostate cryoablation.
    Levy DA; Ross AE; ElShafei A; Krishnan N; Hatem A; Jones JS
    J Urol; 2014 Nov; 192(5):1380-4. PubMed ID: 24813344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of disease burden on cryoablation prostate-specific antigen outcomes.
    Levy DA; Li J; Jones S
    Urology; 2010 Feb; 75(2):478-81. PubMed ID: 19963251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?
    Nielsen ME; Makarov DV; Humphreys E; Mangold L; Partin AW; Walsh PC
    Urology; 2008 Aug; 72(2):389-93; discussion 394-5. PubMed ID: 18279937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
    Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS
    J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical (prostate-specific antigen) relapse-free survival and toxicity after 125I low-dose-rate prostate brachytherapy.
    Khaksar SJ; Laing RW; Henderson A; Sooriakumaran P; Lovell D; Langley SE
    BJU Int; 2006 Dec; 98(6):1210-5. PubMed ID: 17034501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.
    Ganzer R; Robertson CN; Ward JF; Brown SC; Conti GN; Murat FJ; Pasticier G; Rebillard X; Thuroff S; Wieland WF; Blana A
    BJU Int; 2011 Oct; 108(8 Pt 2):E196-201. PubMed ID: 21332907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy.
    Cohen JK; Miller RJ; Ahmed S; Lotz MJ; Baust J
    Urology; 2008 Mar; 71(3):515-8. PubMed ID: 18342200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
    J Urol; 2009 Nov; 182(5):2250-5. PubMed ID: 19758614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer.
    Donnelly BJ; Saliken JC; Brasher PM; Ernst SD; Rewcastle JC; Lau H; Robinson J; Trpkov K
    Cancer; 2010 Jan; 116(2):323-30. PubMed ID: 19937954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience.
    Koppie TM; Shinohara K; Grossfeld GD; Presti JC; Carroll PR
    J Urol; 1999 Aug; 162(2):427-32. PubMed ID: 10411051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.
    Lambert EH; Bolte K; Masson P; Katz AE
    Urology; 2007 Jun; 69(6):1117-20. PubMed ID: 17572198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In patients experiencing biochemical failure after radiotherapy, pretreatment risk group and PSA velocity predict differences in overall survival and biochemical failure-free interval.
    Soto DE; Andridge RR; Pan CC; Williams SG; Taylor JM; Sandler HM
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1295-301. PubMed ID: 18472361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryosurgical ablation of the prostate: high risk patient outcomes.
    Prepelica KL; Okeke Z; Murphy A; Katz AE
    Cancer; 2005 Apr; 103(8):1625-30. PubMed ID: 15747374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience.
    Nobes JP; Wells IG; Khaksar SJ; Money-Kyrle JF; Laing RW; Langley SE
    Prostate Cancer Prostatic Dis; 2009; 12(1):61-6. PubMed ID: 18427571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation.
    Ellis DS; Manny TB; Rewcastle JC
    Urology; 2007 Feb; 69(2):306-10. PubMed ID: 17320669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients.
    Ismail M; Ahmed S; Kastner C; Davies J
    BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.